应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
BMY 施贵宝
休市中 12-20 15:59:59 EST
57.28
+0.98
+1.74%
盘后
57.54
+0.21
+0.36%
19:59 EST
最高
57.33
最低
56.08
成交量
4,821万
今开
56.29
昨收
56.30
日振幅
2.22%
总市值
1,162亿
流通市值
1,160亿
总股本
20.28亿
成交额
27.29亿
换手率
2.38%
流通股本
20.24亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
百时美施贵宝上涨1.22%，报56.985美元/股
金融界 · 12-21 01:53
百时美施贵宝上涨1.22%，报56.985美元/股
百时美施贵宝重获RayzeBio管线产品在大中华区市场独家开发和商业化权利
界面 · 12-20 10:50
百时美施贵宝重获RayzeBio管线产品在大中华区市场独家开发和商业化权利
百时美施贵宝下跌1.21%，报56.155美元/股
金融界 · 12-20 01:02
百时美施贵宝下跌1.21%，报56.155美元/股
百时美施贵宝：放弃与两家公司的细胞治疗协议
生物药大时代 · 12-19
百时美施贵宝：放弃与两家公司的细胞治疗协议
百时美施贵宝上涨3.01%，报57.55美元/股
金融界 · 12-18
百时美施贵宝上涨3.01%，报57.55美元/股
港股异动 | 方舟健客(06086)涨超10% 与百时美施贵宝达成战略合作 将共同推动行业创新发展
智通财经 · 12-17
港股异动 | 方舟健客(06086)涨超10% 与百时美施贵宝达成战略合作 将共同推动行业创新发展
开启智慧医疗新篇章 | 方舟健客(06086)携手百时美施贵宝 共推行业创新发展
智通财经网 · 12-17
开启智慧医疗新篇章 | 方舟健客(06086)携手百时美施贵宝 共推行业创新发展
百时美施贵宝下跌1.29%，报55.554美元/股
金融界 · 12-13
百时美施贵宝下跌1.29%，报55.554美元/股
百时美施贵宝下跌1.22%，报55.96美元/股
金融界 · 12-13
百时美施贵宝下跌1.22%，报55.96美元/股
顶级亿万富豪投资者的五笔股票买卖
福布斯中文网 · 12-12
顶级亿万富豪投资者的五笔股票买卖
健康巡回：新型联合疗法有望治疗血癌
路透中文 · 12-11
健康巡回：新型联合疗法有望治疗血癌
美国研究综述-Jll、Mongodb、Rigel 制药公司
路透中文 · 12-10
美国研究综述-Jll、Mongodb、Rigel 制药公司
【券商聚焦】花旗：艾伯维(ABBV)与施贵宝(BMY)增长潜力显著 行业聚焦商业化与新药管线
金吾财讯 · 12-06
【券商聚焦】花旗：艾伯维(ABBV)与施贵宝(BMY)增长潜力显著 行业聚焦商业化与新药管线
百时美施贵宝上涨1.22%，报59.08美元/股
金融界 · 12-06
百时美施贵宝上涨1.22%，报59.08美元/股
独家-消息人士称，大型对冲基金向医生和科学家求助，以求在制药业获得优势
路透中文 · 12-04
独家-消息人士称，大型对冲基金向医生和科学家求助，以求在制药业获得优势
百时美施贵宝下跌1.22%，报59.21美元/股
金融界 · 12-04
百时美施贵宝下跌1.22%，报59.21美元/股
创新背后的“患者中心论”——专访百时美施贵宝陈思渊
财富中文网 · 12-03
创新背后的“患者中心论”——专访百时美施贵宝陈思渊
BUZZ-Cytokinetics 因心脏病药物的标准审查而失败
Reuters · 12-02
BUZZ-Cytokinetics 因心脏病药物的标准审查而失败
百时美施贵宝两款创新药纳入国家医保目录
人民日报健康客... · 11-29
百时美施贵宝两款创新药纳入国家医保目录
百时美施贵宝陈思渊：让创新惠及更多患者
第一财经 · 11-29
百时美施贵宝陈思渊：让创新惠及更多患者
加载更多
公司概况
公司名称：
施贵宝
所属市场：
NYSE
上市日期：
--
主营业务：
百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司，通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。
发行价格：
--
{"stockData":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施贵宝","latestPrice":57.28,"timestamp":1734728399731,"preClose":56.3,"halted":0,"volume":48212069,"hourTrading":{"tag":"盘后","latestPrice":57.5368,"preClose":57.33,"latestTime":"19:59 EST","volume":8706431,"amount":499139791.602476,"timestamp":1734742799787},"delay":0,"floatShares":2024362484,"shares":2028176674,"eps":-3.581986,"marketStatus":"休市中","marketStatusCode":7,"change":0.98,"latestTime":"12-20 15:59:59 EST","open":56.29,"high":57.33,"low":56.0812,"amount":2728512097.351516,"amplitude":0.022181,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.581986,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":-18475200000,"adjPreClose":56.3,"adrRate":0,"dividendRate":0.041899,"preHourTrading":{"tag":"盘前","latestPrice":56.21,"preClose":56.3,"latestTime":"09:29 EST","volume":2066675,"amount":116347714.07545,"timestamp":1734704978316},"postHourTrading":{"tag":"盘后","latestPrice":57.5368,"preClose":57.33,"latestTime":"19:59 EST","volume":8706431,"amount":499139791.602476,"timestamp":1734742799787},"volumeRatio":3.6269059301660205,"impliedVol":0.278,"impliedVolPercentile":0.3294},"requestUrl":"/m/hq/s/BMY","defaultTab":"news","newsList":[{"id":"2493228684","title":"百时美施贵宝上涨1.22%，报56.985美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493228684","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493228684?lang=zh_cn&edition=full","pubTime":"2024-12-21 01:53","pubTimestamp":1734717220,"startTime":"0","endTime":"0","summary":"12月21日，百时美施贵宝(BMY)盘中上涨1.22%，截至01:53，报56.985美元/股，成交5.07亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：12月16日，百时美施贵宝获Jefferies上调评级至Buy，目标价上调至70美元。2025年2月6日，百时美施贵宝将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/21015346668806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1032466523.USD","BK4534","LU2242646821.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU1670711040.USD","BK4532","LU1670711123.USD","LU1868836757.USD","LU1093756168.USD","LU1571399168.USD","BK4007","LU0321505868.SGD","LU0456855351.SGD","BK4559","IE00B2B36J28.USD","BK4588","LU0096364046.USD","LU1868836914.USD","LU1074936037.SGD","LU1868836591.USD","LU0237698245.USD","IE0002141913.USD","LU1670710588.SGD","BMY","BK4585","LU0985481810.HKD","LU2242652126.USD","LU0306806265.USD","LU1430594728.SGD","LU0225771236.USD","LU1670710661.SGD","IE00BJT1NW94.SGD","LU0225284248.USD","LU1261432733.SGD","LU2125154778.USD","IE00BSNM7G36.USD","BK4581","LU0306807586.USD","LU1585245621.USD","LU1718418525.SGD","LU1093756325.SGD","LU0882574055.USD","IE0009355771.USD","LU1868837136.USD","LU1323610961.USD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0061475181.USD","LU2125154935.USD"],"gpt_icon":0},{"id":"2492025451","title":"百时美施贵宝重获RayzeBio管线产品在大中华区市场独家开发和商业化权利","url":"https://stock-news.laohu8.com/highlight/detail?id=2492025451","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492025451?lang=zh_cn&edition=full","pubTime":"2024-12-20 10:50","pubTimestamp":1734663022,"startTime":"0","endTime":"0","summary":"12月19日，百时美施贵宝宣布，公司已与艾博兹医药达成了一项协议，百时美施贵宝重新取得了在大中华区开发和商业化ABZ-706（相当于RYZ801）的独家权利，该管线产品用于针对GPC3靶点的肝细胞癌治疗，同时也终止了与艾博兹之前签订的一项广泛授权协议，该协议授予艾博兹对RayzeBio至多四个管线产品（包括ABZ-706）在这些市场的开发和商业化权利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220105022ab85db0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220105022ab85db0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1430594728.SGD","LU2360032135.SGD","LU1093756325.SGD","BK4559","BK4588","LU2133065610.SGD","LU1868837300.USD","IE0009355771.USD","IE0002141913.USD","LU1323610961.USD","LU0225284248.USD","LU1868836757.USD","LU2242652126.USD","BMY","LU0096364046.USD","LU0456855351.SGD","LU1868837136.USD","IE00B2B36J28.USD","RYZB","BK4139","LU1670710588.SGD","LU1670710661.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","LU1670711040.USD","LU1571399168.USD","LU1718418525.SGD","LU1868836591.USD","IE00BSNM7G36.USD","LU1261432733.SGD","LU0985481810.HKD","IE00BJJMRZ35.SGD","BK4581","BK4532","LU1074936037.SGD","LU1291159041.SGD","LU1868836914.USD","BK4585","LU0306806265.USD","LU0225771236.USD","LU0868494617.USD","BK4534","LU0237698245.USD","LU0114720955.EUR","LU0306807586.USD","LU0321505868.SGD","LU1093756168.USD","LU1032466523.USD","IE00BFTCPJ56.SGD","LU0882574055.USD"],"gpt_icon":0},{"id":"2492101856","title":"百时美施贵宝下跌1.21%，报56.155美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492101856","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492101856?lang=zh_cn&edition=full","pubTime":"2024-12-20 01:02","pubTimestamp":1734627760,"startTime":"0","endTime":"0","summary":"12月20日，百时美施贵宝(BMY)盘中下跌1.21%，截至01:02，报56.155美元/股，成交1.69亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：12月16日，百时美施贵宝获Jefferies上调评级至Buy，目标价上调至70美元。2025年2月6日，百时美施贵宝将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/20010246614838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4534","BK4588","LU1430594728.SGD","LU1670710588.SGD","LU0321505439.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU1261432733.SGD","LU2242646821.SGD","LU0306807586.USD","LU0096364046.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","IE00BJJMRZ35.SGD","LU1074936037.SGD","LU1868837300.USD","LU0321505868.SGD","LU0225771236.USD","LU1670711123.USD","LU0061475181.USD","LU2125154778.USD","LU2125154935.USD","LU1291159041.SGD","BK4007","BK4559","LU1670710661.SGD","LU1670711040.USD","IE00BSNM7G36.USD","BK4581","LU0306806265.USD","LU1093756325.SGD","LU1585245621.USD","LU0868494617.USD","LU1868836757.USD","LU0985481810.HKD","LU1323610961.USD","BMY","LU1989771016.USD","LU0225284248.USD","LU2242652126.USD","LU0456855351.SGD","LU1718418525.SGD","LU2133065610.SGD","LU0882574055.USD","LU2360032135.SGD","BK4532","BK4585","LU1093756168.USD","IE0009355771.USD","LU1032466523.USD"],"gpt_icon":0},{"id":"2492701194","title":"百时美施贵宝：放弃与两家公司的细胞治疗协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2492701194","media":"生物药大时代","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492701194?lang=zh_cn&edition=full","pubTime":"2024-12-19 11:33","pubTimestamp":1734579207,"startTime":"0","endTime":"0","summary":"百时美施贵宝公司将终止与 Immatics 的两项细胞治疗合作，并取消与 Century Therapeutics 关于基于自然杀伤细胞和 T 细胞的癌症治疗的单独协议。这些似乎是百时美施贵宝 在 4 月份宣布的节省 15 亿澳元的详细计划带来的最新变化。BMS 和 Immatics 于 2019 年开始合作，当时这家制药公司为这家生物技术公司的三个 T 细胞受体治疗靶点提供了 7500 万美元的预付款。根据周五公布的美国证券交易委员会 文件，在最近的打击中，百时美施贵宝终止了对 2019 年原始协议的两次扩展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219113637a1fa2621&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219113637a1fa2621&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BSNM7G36.USD","LU0061475181.USD","LU1989771016.USD","LU0114720955.EUR","LU0985481810.HKD","LU1868837300.USD","LU1868837136.USD","LU1291159041.SGD","LU2360032135.SGD","LU1718418525.SGD","LU1323610961.USD","BK4007","LU1585245621.USD","LU1074936037.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4585","LU2242652126.USD","LU2125154935.USD","LU2242646821.SGD","LU1868836914.USD","BK4559","LU1670711040.USD","BMY","LU1670711123.USD","LU1430594728.SGD","LU2133065610.SGD","LU2125154778.USD","LU1093756325.SGD","IE0009355771.USD","LU1261432733.SGD","LU1032466523.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU0321505439.SGD","IE0002141913.USD","LU0225771236.USD","BK4581","LU0882574055.USD","BK4532","LU0096364046.USD","BK4534","LU1093756168.USD","BK4588","LU1868836591.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2492826918","title":"百时美施贵宝上涨3.01%，报57.55美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492826918","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492826918?lang=zh_cn&edition=full","pubTime":"2024-12-18 04:48","pubTimestamp":1734468510,"startTime":"0","endTime":"0","summary":"12月18日，百时美施贵宝(BMY)盘中上涨3.01%，截至04:48，报57.55美元/股，成交5.08亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：12月16日，百时美施贵宝获Jefferies上调评级至Buy，目标价上调至70美元。2025年2月6日，百时美施贵宝将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/18044846514858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4581","LU2125154935.USD","IE00BSNM7G36.USD","LU0096364046.USD","BK4534","LU1585245621.USD","LU2242652126.USD","LU1868837136.USD","LU0225284248.USD","LU1868836914.USD","LU0321505868.SGD","LU0306807586.USD","IE00BJT1NW94.SGD","LU1261432733.SGD","IE00B2B36J28.USD","BMY","LU1323610961.USD","LU1093756168.USD","LU1291159041.SGD","BK4007","LU1868836591.USD","LU1670711040.USD","LU0237698245.USD","LU1868836757.USD","LU1074936037.SGD","LU2242646821.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","LU1868837300.USD","LU1670710588.SGD","LU0061475181.USD","LU1670710661.SGD","LU2133065610.SGD","BK4559","LU1670711123.USD","IE0002141913.USD","IE0009355771.USD","LU1430594728.SGD","BK4585","LU1093756325.SGD","LU1032466523.USD","LU0868494617.USD","LU0985481810.HKD","LU2360032135.SGD","LU1989771016.USD","BK4588","BK4532","IE00BJJMRZ35.SGD","LU0225771236.USD","LU2125154778.USD"],"gpt_icon":0},{"id":"2492346981","title":"港股异动 | 方舟健客(06086)涨超10% 与百时美施贵宝达成战略合作 将共同推动行业创新发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2492346981","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492346981?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:11","pubTimestamp":1734419477,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，方舟健客(06086)涨超10%，截至发稿，涨10.66%，报6.75港元，成交额458.62万港元。消息面上，12月16日，方舟健客与百时美施贵宝中国战略合作签约仪式在上海举办，双方签署战略合作协议，将就数字医疗平台建设及互联网健康管理模式升级等方面开展深度合作。据了解，本次战略合作将重点围绕β-地中海贫血的治疗药物利布洛泽®、银屑病治疗用药颂狄多®展开深度合作，探索创新的数智化营销项目管理模式。值得一提的是，利布洛泽®日前成功续约国家医保目录，其今年申报的新适应症有望在2025年获批；颂狄多®也在今年正式纳入了国家医保目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1670710588.SGD","LU1868836591.USD","LU0456855351.SGD","IE0009355771.USD","LU0868494617.USD","LU1291159041.SGD","LU1074936037.SGD","LU0306807586.USD","IE00BFTCPJ56.SGD","06086","IE00B2B36J28.USD","BK4559","LU0985481810.HKD","LU2133065610.SGD","LU1868837136.USD","BK4585","LU0321505868.SGD","LU1868836914.USD","LU1323610961.USD","LU1571399168.USD","LU0225284248.USD","BK4534","BK4532","IE0002141913.USD","LU0225771236.USD","BK4588","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1261432733.SGD","LU0061475181.USD","LU0114720955.EUR","LU1868837300.USD","LU0306806265.USD","BK1247","LU1585245621.USD","LU1989771016.USD","LU1093756325.SGD","BK4581","BMY","LU2360032135.SGD","LU1032466523.USD","LU2242652126.USD","LU1868836757.USD","LU1718418525.SGD","LU2242646821.SGD","LU1430594728.SGD","LU1670710661.SGD","LU1670711123.USD","LU1670711040.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2492604985","title":"开启智慧医疗新篇章 | 方舟健客(06086)携手百时美施贵宝 共推行业创新发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2492604985","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492604985?lang=zh_cn&edition=full","pubTime":"2024-12-17 12:06","pubTimestamp":1734408400,"startTime":"0","endTime":"0","summary":"12月16日，方舟健客(06086)与百时美施贵宝(BMY.US)中国战略合作签约仪式在上海举办。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20241217/20241217120650_30043.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241217/20241217120650_30043.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1032466523.USD","LU0306807586.USD","LU1670710588.SGD","LU2125154935.USD","LU0061475181.USD","LU1093756325.SGD","LU1868837136.USD","BK4532","BK1247","BK4581","LU0868494617.USD","LU0225771236.USD","LU1261432733.SGD","LU1868836757.USD","BK4559","IE00B2B36J28.USD","IE0002141913.USD","LU1670711123.USD","BK4588","LU0096364046.USD","LU0306806265.USD","LU0225284248.USD","LU0321505868.SGD","LU1074936037.SGD","LU1670711040.USD","LU1868836914.USD","LU1868837300.USD","LU1585245621.USD","LU2242652126.USD","LU1670710661.SGD","LU0456855351.SGD","LU2125154778.USD","LU1571399168.USD","06086","LU0114720955.EUR","LU0882574055.USD","IE00BFTCPJ56.SGD","LU1868836591.USD","BK4585","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU2133065610.SGD","LU2360032135.SGD","BMY","LU1093756168.USD","IE00BSNM7G36.USD","LU1989771016.USD","LU1430594728.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2491375129","title":"百时美施贵宝下跌1.29%，报55.554美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491375129","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491375129?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:35","pubTimestamp":1734100547,"startTime":"0","endTime":"0","summary":"12月13日，百时美施贵宝(BMY)盘中下跌1.29%，截至22:35，报55.554美元/股，成交1575.75万美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：12月11日，百时美施贵宝2024季度分配每1股派0.62美元股息，除权除息日2025-01-03，派息日2025-02-03。2025年2月6日，百时美施贵宝将于(美东)盘前披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/13223546380369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1032466523.USD","IE00B2B36J28.USD","BK4585","LU0868494617.USD","LU1670710661.SGD","LU0306806265.USD","LU1868836591.USD","LU2242646821.SGD","LU1585245621.USD","LU0882574055.USD","LU2242652126.USD","LU1868837136.USD","LU1074936037.SGD","BK4588","LU0225284248.USD","LU1868837300.USD","LU0096364046.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU0321505868.SGD","LU0237698245.USD","IE00BSNM7G36.USD","LU1868836757.USD","LU1323610961.USD","IE00BJJMRZ35.SGD","BMY","LU1430594728.SGD","BK4581","LU1093756325.SGD","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU2125154935.USD","LU1670711123.USD","LU1670710588.SGD","LU0114720955.EUR","LU1868836914.USD","LU1718418525.SGD","LU2133065610.SGD","IE0009355771.USD","LU1261432733.SGD","LU0306807586.USD","LU1989771016.USD","LU0985481810.HKD","LU1093756168.USD","LU1670711040.USD","LU2360032135.SGD","IE0002141913.USD","BK4007","LU0321505439.SGD","BK4534"],"gpt_icon":0},{"id":"2491353598","title":"百时美施贵宝下跌1.22%，报55.96美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491353598","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491353598?lang=zh_cn&edition=full","pubTime":"2024-12-13 02:52","pubTimestamp":1734029554,"startTime":"0","endTime":"0","summary":"12月13日，百时美施贵宝(BMY)盘中下跌1.22%，截至02:52，报55.96美元/股，成交3.39亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。大事提醒：12月10日，百时美施贵宝获美国银行重申评级Neutral，目标价上调至63美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/13025246339865.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE0002141913.USD","LU0985481810.HKD","LU1074936037.SGD","LU1430594728.SGD","BK4534","LU1571399168.USD","LU2125154778.USD","BMY","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU2242652126.USD","LU1093756168.USD","LU1868836591.USD","LU2242646821.SGD","BK4559","LU2360032135.SGD","LU1323610961.USD","BK4581","LU1261432733.SGD","LU1868836757.USD","LU1868837136.USD","BK4007","LU0882574055.USD","BK4585","LU1585245621.USD","LU0321505439.SGD","BK4588","LU1868836914.USD","LU1868837300.USD","LU1093756325.SGD","LU1032466523.USD","LU1670711123.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU0061475181.USD","BK4532","LU1670710661.SGD","LU0456855351.SGD","LU1670711040.USD","IE00BFTCPJ56.SGD","LU0306807586.USD","IE00BSNM7G36.USD","LU0868494617.USD","LU1291159041.SGD","LU1670710588.SGD","LU0096364046.USD","LU1989771016.USD","LU0114720955.EUR","LU0237698245.USD"],"gpt_icon":0},{"id":"2490724588","title":"顶级亿万富豪投资者的五笔股票买卖","url":"https://stock-news.laohu8.com/highlight/detail?id=2490724588","media":"福布斯中文网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490724588?lang=zh_cn&edition=full","pubTime":"2024-12-12 17:08","pubTimestamp":1733994480,"startTime":"0","endTime":"0","summary":"原文标题：《顶级亿万富豪投资者的五笔股票买卖》过去30个月里，我们构建了两个《福布斯》亿万富豪投资者模拟投资组合。在决定采取何种策略时，我们的主要参考因素之一就是亿万富豪投资者们公开的操作动向。《福布斯》观察了最富有的五位白手起家亿万富豪投资者的五笔最大买入和五笔最大卖出操作，得出25个有趣的洞察，巴菲特购入达美乐股份便是其一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-12-12/doc-inczezhn9699146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SPY","T","LYFT","CVX","DPZ","VST","KVUE","COF","MSFT","HEI","MAR","COP","NVDA","RCL","FOXA","UPRO","NVDD","FIX","BRK.A","PDD","EQIX","BMY","AAPL","CHTR","EME","CMCSA","MDT","META","TLN","BAC","NRG","EQT","SIRI","NVDY","ESmain","03145","TEAM","BRK.B"],"gpt_icon":1},{"id":"2490023042","title":"健康巡回：新型联合疗法有望治疗血癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2490023042","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490023042?lang=zh_cn&edition=full","pubTime":"2024-12-11 04:36","pubTimestamp":1733863013,"startTime":"0","endTime":"0","summary":"三联药物疗法有望治疗血癌 研究人员在美国血液学学会 会议上报告说，新型三联药物疗法有望治疗各种白血病患者。该疗法的总体反应率为 82%。\"我们看到的结果确实将这种三联疗法定位为一种潜在的标准治疗方案。\"如今，我们有几位患者已经不再接受治疗，而是通过定期的血液MRD检测进行监测。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4S3NB1LV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","IE00BVYPNV92.GBP","LU2324357040.USD","SG9999018865.SGD","LU0029864427.USD","LU2360032135.SGD","LU2491050071.SGD","SNDX","LU1323610961.USD","SG9999017495.SGD","LLY","LU1074936037.SGD","LU1366192091.USD","LU2461242641.AUD","LU0006306889.USD","IE00B2B36J28.USD","LU2264538146.SGD","ABBV","BK4139","LU2242652126.USD","LU0965509010.AUD","BK4559","LU2347655156.SGD","BMY","LU1023059063.AUD","LU2133065610.SGD","LU1035775433.USD","LU1732799900.SGD","LU0965509101.SGD","LU1712237335.SGD","LU2125154778.USD","LU0823416689.USD","SG9999015952.SGD","SGXZ31699556.SGD","LU0310799852.SGD","LU0109391861.USD","LU0738911758.USD","IE00B3PB1722.GBP","LU1551013425.SGD","LU1261432733.SGD","LU1496350502.SGD","SG9999015978.USD","LU0820561818.USD","LU2237443622.USD","LU0225771236.USD","IE00B4R5TH58.HKD","LU0079474960.USD","LU0553294199.USD","LU1003077747.HKD","LU2237443382.USD"],"gpt_icon":1},{"id":"2490006865","title":"美国研究综述-Jll、Mongodb、Rigel 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2490006865","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490006865?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:14","pubTimestamp":1733814845,"startTime":"0","endTime":"0","summary":"美国研究综述-Jll、Mongodb、Rigel 制药公司路透12月10日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Jll、Mongodb 和 Rigel Pharmaceuticals。要闻 * Jll JLL.N：KBW将目标价从292美元上调至325美元 * Mongodb Inc MDB.O：巴克莱将目标价从375美元上调至400美元 * Rigel Pharmaceuticals Inc RIGL.O：B. Riley将目标价从27美元下调至20美元 * Rocket Companies Inc RKT.N：KBW 将其评级从 \"市场表现 \"下调至 \"表现不佳\"。* UWM Holdings Corp UWMC.N：KBW将目标价从9美元下调至7美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nL4S3NB0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIGL","LU2272731782.SGD","LU0203345920.USD","BK4547","LU0061475181.USD","LU0965508806.USD","GNW","LU2357305700.SGD","SLG","FNF","LU2106854487.HKD","SG9999001440.SGD","MDB","PFSI","VIRC","LU1116320901.HKD","SG9999014542.SGD","BMY","BK4143","MFA","LU0114720955.EUR","MRK","SF","BK4223","IE0002141913.USD","LU0225771236.USD","UWMC","FAF","LU0353189680.USD","IE00BJJMRZ35.SGD","VOYA","LU0963586101.USD","LU0390134368.USD","LU0965509101.SGD","LU2089984988.USD","NMIH","LU1992135399.USD","MTG","LU2272731600.USD","STC","LU0320765489.SGD","LU1037948541.HKD","SG9999001176.SGD","JLL","LU1868836591.USD","BK4194","RKT","ACT","LU1571399168.USD"],"gpt_icon":1},{"id":"2489263134","title":"【券商聚焦】花旗：艾伯维(ABBV)与施贵宝(BMY)增长潜力显著 行业聚焦商业化与新药管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2489263134","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489263134?lang=zh_cn&edition=full","pubTime":"2024-12-06 10:53","pubTimestamp":1733453617,"startTime":"0","endTime":"0","summary":"会议重点讨论了艾伯维和施贵宝等公司的最新商业执行情况、临床催化剂以及近期推出的产品和标签扩展机会。关于艾伯维，花旗认为公司的重点将继续是Skyrizi和Rinvoq的商业化执行，以及其美容业务的反弹潜力和emraclidine的下一步计划。Skyrizi在溃疡性结肠炎中的增长与克罗恩病的增长相一致，显示出高效力和市场对生物制剂的高接受度。花旗对该公司维持“买入”评级，目标价215美元。对于百时美施贵宝，花旗认为公司的新药上市和管线是缓解收入低谷的关键。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/NjJlY2NjZTdjZjEwMTc4NjkxNjc4NQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjJlY2NjZTdjZjEwMTc4NjkxNjc4NQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"282857","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU2462157665.USD","LU0985481810.HKD","LU0198837287.USD","LU2417539215.USD","LU1267930490.SGD","LLY","LU0170899867.USD","SG9999013999.USD","LU0128525689.USD","LU0321505868.SGD","LU0417517546.SGD","LU2602419157.SGD","LU0738911758.USD","SG9999015978.USD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","BK4599","BMY","LU0943347566.SGD","LU1366192091.USD","LU0949170772.SGD","LU1670710588.SGD","LU0029864427.USD","BIIB","LU0203202063.USD","LU0211327993.USD","LU0661504455.SGD","LU2265009873.SGD","BK4566","IE00B3PB1722.GBP","LU1571399168.USD","IE00BJT1NW94.SGD","LU1989771016.USD","BK4581","IE00B2B36J28.USD","LU0310800965.SGD","LU1003077747.HKD","LU0354030511.USD","ABBV","LU2491050154.USD","LU0385154629.USD","LU2264538146.SGD","LU2361045086.USD","IE00BDGV0183.EUR","LU0256863902.USD","LU1791807156.HKD","IE00B4R5TH58.HKD","LU1934455194.USD"],"gpt_icon":1},{"id":"2489462070","title":"百时美施贵宝上涨1.22%，报59.08美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489462070","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489462070?lang=zh_cn&edition=full","pubTime":"2024-12-06 00:29","pubTimestamp":1733416180,"startTime":"0","endTime":"0","summary":"12月6日，百时美施贵宝(BMY)盘中上涨1.22%，截至00:29，报59.08美元/股，成交1.1亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/06002946082975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU2133065610.SGD","LU0225771236.USD","LU0306807586.USD","IE00BJT1NW94.SGD","LU1323610961.USD","LU2242646821.SGD","LU1261432733.SGD","LU2125154778.USD","LU1670711123.USD","LU1430594728.SGD","LU0985481810.HKD","LU0237698245.USD","IE00BSNM7G36.USD","LU1868836914.USD","LU1868836757.USD","BK4581","LU2360032135.SGD","LU1093756325.SGD","LU1868836591.USD","BK4588","IE00B2B36J28.USD","LU0061475181.USD","BMY","LU0868494617.USD","LU1670710661.SGD","BK4559","LU0096364046.USD","LU1670710588.SGD","LU1868837136.USD","LU1989771016.USD","LU1670711040.USD","BK4534","LU0456855351.SGD","LU0306806265.USD","BK4532","LU1585245621.USD","LU0321505868.SGD","LU0225284248.USD","LU0114720955.EUR","LU1093756168.USD","LU2125154935.USD","LU0321505439.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1718418525.SGD","LU0882574055.USD","BK4007"],"gpt_icon":0},{"id":"2488713604","title":"独家-消息人士称，大型对冲基金向医生和科学家求助，以求在制药业获得优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2488713604","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488713604?lang=zh_cn&edition=full","pubTime":"2024-12-04 14:00","pubTimestamp":1733292024,"startTime":"0","endTime":"0","summary":"独家-消息人士称，大型对冲基金向医生和科学家求助，以求在制药业获得优势招聘医生的趋势从美国蔓延至欧洲--招聘公司借贷成本下降，医药研发支出有望增加欧洲企业今年财报日波动较大Nell Mackenzie. 路透社伦敦12月4日 - 八位消息人士告诉路透社，全球最大的一些对冲基金正在招聘医生、科学家和分析师，以便在医药行业股价大幅波动后对该行业的前景有专业的见解。专家们指出，多策略对冲基金是造成这种现象的原因之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241204:nL3S3N50CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU0985320562.USD","LU1323610961.USD","ABBV","LU0661504455.SGD","LU1732799900.SGD","LU2237443622.USD","LU1551013342.USD","LU2237443549.SGD","BMY","LU0203347892.USD","SG9999001440.SGD","LU2237443465.HKD","LU0820561909.HKD","LU1430594728.SGD","LU2125154778.USD","LU0203345920.USD","LU0321505868.SGD","LU1551013425.SGD","LU1267930490.SGD","LU1244550494.USD","LU1571399168.USD","LU1585245621.USD","LU2237443895.HKD","LU0861579265.USD","LU2087621335.USD","IE0002141913.USD","LU1868836914.USD","LU0158827948.USD","LU0708994859.HKD","LU0820561818.USD","LU1032466523.USD","LU0310800379.SGD","LU1261432733.SGD","LU1868837136.USD","IE00BGHQF631.EUR","LU1989772840.SGD","BK4585","LU0868494617.USD","SG9999015978.USD","LU1732800096.USD","LU1983299246.USD","LU2237443978.SGD","LU2089283258.USD","LU0795875086.SGD","LU0985481810.HKD","BK4566","LU2112291526.USD","BK4559","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2488921092","title":"百时美施贵宝下跌1.22%，报59.21美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488921092","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488921092?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:17","pubTimestamp":1733249844,"startTime":"0","endTime":"0","summary":"12月4日，百时美施贵宝(BMY)盘中下跌1.22%，截至02:17，报59.21美元/股，成交1.95亿美元。财务数据显示，截至2024年09月30日，百时美施贵宝收入总额359.58亿美元，同比增长7.24%；归母净利润-90.2亿美元，同比减少244.02%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/04021745980713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0868494617.USD","BK4588","LU1868836757.USD","LU1670710661.SGD","IE00BSNM7G36.USD","LU0882574055.USD","LU1093756168.USD","LU0456855351.SGD","LU1585245621.USD","LU0096364046.USD","LU0061475181.USD","IE00BJT1NW94.SGD","LU1323610961.USD","BK4559","LU0306807586.USD","LU1670711040.USD","LU2133065610.SGD","LU1430594728.SGD","LU2125154778.USD","LU1670711123.USD","LU0985481810.HKD","LU2360032135.SGD","BMY","BK4532","LU1291159041.SGD","LU0114720955.EUR","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0225771236.USD","LU1074936037.SGD","LU1670710588.SGD","LU2242652126.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1718418525.SGD","LU0225284248.USD","LU0321505439.SGD","LU1989771016.USD","LU1261432733.SGD","BK4007","IE0009355771.USD","BK4534","LU1032466523.USD","LU1868836591.USD","BK4581","LU0306806265.USD","LU1868837136.USD","LU1868837300.USD","LU1093756325.SGD","LU1571399168.USD"],"gpt_icon":0},{"id":"2488185816","title":"创新背后的“患者中心论”——专访百时美施贵宝陈思渊","url":"https://stock-news.laohu8.com/highlight/detail?id=2488185816","media":"财富中文网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488185816?lang=zh_cn&edition=full","pubTime":"2024-12-03 21:00","pubTimestamp":1733230840,"startTime":"0","endTime":"0","summary":"日前，《财富》世界500强百时美施贵宝（BMS）宣布，公司的三款创新药物已被纳入最新版中国国家医保目录，其中包括用于治疗中重度斑块状银屑病的氘可来昔替尼片以及用于治疗梗阻性肥厚型心肌病的玛伐凯泰胶囊。这两款“同类首创”的创新药都是今年在中国上市的。此外，就在今年10月，BMS的“免疫双子星”O药联合Y药获得中国...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OYDgfbwZ5SRNe3lLd6APAbHE-ivjMninOH1BXHc8x7YvkAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OYDgfbwZ5SRNe3lLd6APAbHE-ivjMninOH1BXHc8x7YvkAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241203A0988200","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241203A0988200","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["IE00BSNM7G36.USD","LU0061475181.USD","LU1989771016.USD","LU0114720955.EUR","LU0985481810.HKD","LU1868837300.USD","LU2360032135.SGD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1868836757.USD","LU0306806265.USD","LU1718418525.SGD","LU1323610961.USD","BK4007","LU1585245621.USD","LU1074936037.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU0868494617.USD","BK4585","LU2242652126.USD","LU2125154935.USD","LU1670710661.SGD","LU1868836914.USD","BK4559","BMY","LU1430594728.SGD","LU2133065610.SGD","LU2125154778.USD","LU1093756325.SGD","IE0009355771.USD","LU1261432733.SGD","LU1032466523.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","LU1670710588.SGD","IE00BJJMRZ35.SGD","LU0321505439.SGD","LU0225284248.USD","IE0002141913.USD","LU0225771236.USD","BK4581","LU0882574055.USD","LU0096364046.USD","LU0321505868.SGD","LU1868837136.USD","LU1093756168.USD","BK4588","LU1868836591.USD","LU0237698245.USD"],"gpt_icon":0},{"id":"2488315674","title":"BUZZ-Cytokinetics 因心脏病药物的标准审查而失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2488315674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488315674?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:08","pubTimestamp":1733148525,"startTime":"0","endTime":"0","summary":" 12月2日 - ** Cytokinetics 股价盘前下跌2.3%至50.67美元 ** CYTK称美国食品和药物管理局已同意审查其心脏病药物aficamten的上市申请** 美国食品和药物管理局指定的行动日期为 2025 年 9 月 26 日 - CYTK ** 至少有两位分析师表示，由于aficamten的标准审查期与投资者对优先审查的预期不同，CYTK的股价今天可能会走弱，而优先审查可能会导致该药提前上市。** Piper Sandler称，FDA的认可增强了人们对该药成功的信心，并坚信该药的标签不会像Camzyos那么严格。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2133065610.SGD","BK4505","LU0306807586.USD","LU1323610961.USD","LU2242646821.SGD","LU1032466523.USD","LU2125154778.USD","LU1670711123.USD","LU1430594728.SGD","LU0985481810.HKD","LU1571399168.USD","IE00BSNM7G36.USD","LU1868836914.USD","LU1868836757.USD","BK4581","LU1093756325.SGD","LU1868836591.USD","BK4588","CYTK","LU0061475181.USD","BMY","LU1670710661.SGD","BK4559","LU0096364046.USD","LU1670710588.SGD","LU1868837136.USD","LU1989771016.USD","LU1670711040.USD","LU1868837300.USD","BK4534","LU0306806265.USD","BK4532","LU2242652126.USD","LU1291159041.SGD","LU1585245621.USD","LU0321505868.SGD","LU0225284248.USD","LU0114720955.EUR","LU1093756168.USD","LU2125154935.USD","LU0321505439.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","IE00BFTCPJ56.SGD","LU1074936037.SGD","IE0002141913.USD","LU0882574055.USD","BK4007"],"gpt_icon":0},{"id":"2487585029","title":"百时美施贵宝两款创新药纳入国家医保目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2487585029","media":"人民日报健康客...","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487585029?lang=zh_cn&edition=full","pubTime":"2024-11-29 15:01","pubTimestamp":1732863687,"startTime":"0","endTime":"0","summary":"11月28日，百时美施贵宝旗下全球首创①且目前唯一获批心肌肌球蛋白抑制剂迈凡妥(玛伐凯泰胶囊)、全球首款②口服酪氨酸激酶2(TYK2)变构抑制剂颂狄多(氘可来昔替尼片)纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》。迈凡妥是首款纳入国家医保目录的梗阻性肥厚型心肌病创新治疗药物，用于治疗梗阻性肥厚型心肌病(HCM)成人患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411293254957224.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1032466523.USD","LU0306807586.USD","LU1670710588.SGD","LU2125154935.USD","LU0061475181.USD","LU1093756325.SGD","LU1868837136.USD","BK4532","BK4581","LU0868494617.USD","LU0225771236.USD","LU1261432733.SGD","LU1868836757.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0237698245.USD","LU1670711123.USD","BK4588","LU0306806265.USD","LU0225284248.USD","06978","LU0321505868.SGD","LU1074936037.SGD","LU1670711040.USD","LU1868836914.USD","LU2242646821.SGD","LU1585245621.USD","LU2242652126.USD","LU1670710661.SGD","LU0456855351.SGD","LU2125154778.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU0882574055.USD","BK4007","IE00BFTCPJ56.SGD","BK4585","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU1323610961.USD","LU2133065610.SGD","LU1718418525.SGD","LU2360032135.SGD","BMY","LU1093756168.USD","IE00BSNM7G36.USD","LU1430594728.SGD","IE0009355771.USD","BK1574","BK4534"],"gpt_icon":0},{"id":"2487303541","title":"百时美施贵宝陈思渊：让创新惠及更多患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2487303541","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487303541?lang=zh_cn&edition=full","pubTime":"2024-11-29 11:25","pubTimestamp":1732850742,"startTime":"0","endTime":"0","summary":"今年以来，创新药赛道持续受到政策关注与市场瞩目。我国创新药市场的发展也给跨国药企带来更多机遇。加码中国创新，跨国药企如何布局？第一财经《首席评论》近期专访了百时美施贵宝副总裁、中国及亚洲区域市场总经理陈思渊，共同探讨相关话题。第一财经：百时美施贵宝在2020年提出了 “中国2030战略”，目前进展如何？陈思...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/OQpoyRGS28dQcmlWpmGRSBOAvtDCH70YKrPQ2QEcS_o3AAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OQpoyRGS28dQcmlWpmGRSBOAvtDCH70YKrPQ2QEcS_o3AAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241129A03HSV00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241129A03HSV00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["LU2360032135.SGD","BK4007","LU1868836757.USD","LU1868836914.USD","LU0306806265.USD","LU1291159041.SGD","LU1571399168.USD","LU1718418525.SGD","IE00B2B36J28.USD","LU1093756325.SGD","LU1585245621.USD","BK4532","IE00BSNM7G36.USD","LU1670710588.SGD","LU0061475181.USD","LU1261432733.SGD","LU0114720955.EUR","LU0456855351.SGD","LU0985481810.HKD","LU2242652126.USD","LU0321505439.SGD","LU0868494617.USD","BK4559","LU2242646821.SGD","LU0882574055.USD","LU0237698245.USD","IE00BJT1NW94.SGD","LU1670711040.USD","LU1868837136.USD","LU1074936037.SGD","LU1989771016.USD","BMY","BK4588","LU1670711123.USD","LU1323610961.USD","BK4585","IE0009355771.USD","IE0002141913.USD","LU0306807586.USD","LU0321505868.SGD","BK4581","IE00BJJMRZ35.SGD","LU1093756168.USD","BK4534","LU1868837300.USD","LU1430594728.SGD","LU1032466523.USD","LU2125154935.USD","LU2125154778.USD","LU0225284248.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bms.com","stockEarnings":[{"period":"1week","weight":0.0269},{"period":"1month","weight":-0.0104},{"period":"3month","weight":0.1593},{"period":"6month","weight":0.3661},{"period":"1year","weight":0.1174},{"period":"ytd","weight":0.1164}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"百时美施贵宝公司于1933年8月根据特拉华州法律注册成立，名为百时美公司，继承了1887年在纽约成立的一家企业。1989年，由于合并，公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。他们在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。 他们预计他们对Celgene和MyoKardia的收购将进一步将他们定位为领先的生物制药公司，通过多项近期资产和额外的外部合作伙伴扩大他们的肿瘤学、血液学、免疫学和心血管产品组合。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.013265},{"month":2,"riseRate":0.545455,"avgChangeRate":0.009113},{"month":3,"riseRate":0.636364,"avgChangeRate":0.008429},{"month":4,"riseRate":0.488889,"avgChangeRate":-0.002113},{"month":5,"riseRate":0.577778,"avgChangeRate":0.003555},{"month":6,"riseRate":0.622222,"avgChangeRate":0.010543},{"month":7,"riseRate":0.422222,"avgChangeRate":-0.000341},{"month":8,"riseRate":0.511111,"avgChangeRate":-0.003031},{"month":9,"riseRate":0.533333,"avgChangeRate":0.011131},{"month":10,"riseRate":0.577778,"avgChangeRate":0.025202},{"month":11,"riseRate":0.622222,"avgChangeRate":0.021304},{"month":12,"riseRate":0.622222,"avgChangeRate":0.020908}],"exchange":"NYSE","name":"施贵宝","nameEN":"Bristol-Myers Squibb"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"施贵宝,BMY,施贵宝股票,施贵宝股票老虎,施贵宝股票老虎国际,施贵宝行情,施贵宝股票行情,施贵宝股价,施贵宝股市,施贵宝股票价格,施贵宝股票交易,施贵宝股票购买,施贵宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"施贵宝(BMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供施贵宝(BMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}